yahoo_financeOriginal article
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer
RegulatoryapprovedPTEN IHC Companion DiagnosticPositive
AI Analysis
Summary
NeoGenomics announced FDA approval of its PTEN IHC companion diagnostic for prostate cancer detection and treatment selection.
Outcome Details
FDA-approved PTEN IHC companion diagnostic for prostate cancer
Importance:7/10
Sentiment:
0.80
FDA approvalcompanion diagnosticprostate cancerPTEN IHCregulatory
Related Companies
Read the original article
Published by yahoo_finance on July 9, 2026 11:05 AM